Tempus AI Raises $410M in IPO, Sees Revenue Surge
Tempus AI sold 11M shares at $37 each, launched in 2015, focuses on medical testing, with revenue growth from $320.7M ...
- Latest
- Trending
Tempus AI sold 11M shares at $37 each, launched in 2015, focuses on medical testing, with revenue growth from $320.7M ...
Snowflake stock traded at high multiples and although it may benefit from growth, the long-term outlook and management's actions raise ...
Shares of Ibotta closed up 17% at $103.25, but dropped slightly to $97.38 today. Tech IPO market may not be ...
Chia, founded by Bram Cohen, filed an amended S-1 form and subsequently laid off a third of its staff. The ...
If you're interested in industrial REITs, consider investing in Cityfunds' Exclusive 8% Yield Fund and Americold. Both have strong dividend ...
Shares of Truth Social, the social media platform founded by Donald Trump, fell this week. Trump's stake in the company ...
An 80-year-old woman's financial well-being is a concern as her health deteriorates. Analysts discuss the potential impact of the Trump ...
Phase 1 biotech Boundless Bio raised $100 million at a $396 million market cap. Two IPOs are scheduled for the ...
Stay updated on the latest in biotech with our newsletter and podcast. Boundless becomes the ninth biotech company to go ...
Shares of Reddit closed below their first-day trading price, ending the week at $49.32. They started strong, soaring 30% on ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.